Segelov E, Tattersall M H, Coates A S
Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown NSW, Australia.
Ann Oncol. 1992 Feb;3(2):103-5. doi: 10.1093/oxfordjournals.annonc.a058119.
A double standard exists whereby a treatment given outside a clinical trial is less stringently reviewed than a protocol treatment. We propose a remedy which would require the decision not to participate in an approved, available clinical trial to be subject to the same ethical requirements as trial entry.